Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 3

1(50.0%)

2Total

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06985212Not Yet Recruiting

National Multicentre Study of the Natural History of Acid Sphingo-myelinase Deficiency in Adults and Children

Role: collaborator

NCT04728828Completed

COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients

Role: lead

NCT04852796Completed

Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients

Role: lead

NCT04732481Completed

Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.

Role: lead

NCT04363593Not ApplicableCompleted

Serology COVID-19 From the Cornwall Hospital Union

Role: lead

NCT01731184Phase 3Completed

Morphine-Midazolam in Pre-hospital Traumatic Patients With Severe Acute Pain

Role: lead

All 6 trials loaded